Related Experiment Video
Updated: Apr 8, 2026

04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
1.2K
[SELENIUM EFFICIENCY IN PROPHYLAXIS AND COMPLEX TREATMENT OF DIFFUSE GOITER].
Likars'Ka Sprava
|June 30, 2015
Summary
Combined selenium and iodine treatment effectively reduced thyroid volume in men with diffuse goiter. This combined therapy proved more effective than iodine monotherapy for diffuse goiter management.
Area of Science:
- Endocrinology
- Nutritional Science
Background:
- Diffuse goiter affects men aged 41-50.
- Diagnosis relies on palpation and ultrasound of the thyroid gland.
Purpose of the Study:
- To investigate the efficacy of combined selenium and iodine prophylaxis and treatment for diffuse goiter.
- To compare combined therapy with iodine monotherapy and dynamic supervision.
Main Methods:
- 54 men aged 41-50 with diffuse goiter (1st-2nd degree) were divided into three groups.
- Group 1: Selenium and iodine preparations for 3 months.
- Group 2: Iodine preparations for 3 months.
- Control group: Dynamic supervision.
- Thyroid volume measured and compared to body surface area.
Main Results:
- Combined selenium and iodine therapy led to a significant reduction in thyroid volume (2.15 cm³/M² ± 0.07 cm³/M²).
- 11.8% of patients in the combined therapy group showed normalization of thyroid volume.
- Iodine monotherapy resulted in a less pronounced reduction (0.92 cm³/M² ± 0.17 cm³/M²).
Conclusions:
- Combined selenium and iodine preparations are recommended for diffuse goiter prophylaxis and treatment.
- Effective in areas with combined selenium and mild iodine deficiency.
- Selenium dosage of 100 mcg/day with iodine is suggested.
More Related Videos
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
9.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
9.1K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
69
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69

